(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((3-methylpentan-3-yl)oxy)-4-oxobutanoic acid, 97%, 25g

2,5-Dichloro-4-nitropyridine 1-oxide, 95.0%, 5g

6-Fluoro-2-morpholinonicotinic acid, 97%, 100mg

N-[(1-methylpyrrolidin-3-yl)methyl]ethanamine, 95.0%, 5g

6-Chloro-5-fluoropicolinic acid, 95.0%, 10g

5-Bromo-1,2,4-triazole-3-carbonitrile, 95.0%, 250mg

4-[(3-nitro-1H-pyrazol-1-yl)methyl]benzonitrile, 95.0%, 2g

6-Bromo-N-(2,4-difluorobenzyl)-4-((2,4-dimethoxybenzyl)amino)-1-((3,4-dimethoxybenzyl)oxy)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide, 98%, 50mg

2-(Phenylethynyl)benzaldehyde, 95.0%, 100mg

Colonne capillaire GC ROTI®Cap-5, 30 m, 0,53 mm, 1,00 µm, 1 pièce(s)

(R)-3-CYCLOHEXYLMORPHOLINE, 95%, 250mg

(8-Chloroquinolin-6-yl)boronic acid, 98%, 25g

Triisobutylamine>98.0%(GC)(T)25mL